Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Why Is Vincerx Pharma (VINC) Stock Down 64% Today?

By William White, InvestorPlace Writer
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.

Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today?

By William White, InvestorPlace Writer
MyMD Pharmaceuticals stock is rising on Tuesday as MYMD investors react to a new amendment to a securities purchase agreement.

Why Is Biophytis (BPTS) Stock Up 43% Today?

By William White, InvestorPlace Writer
Biophytis stock is up on Tuesday after the company provided BPTS shareholders with results for the fiscal full year of 2023!

3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April

By Chris MacDonald, InvestorPlace Contributor
These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term.

3 Biotech Stocks to Dump Before They Go to Zero

By Omor Ibne Ehsan
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling.

3 Dirt-Cheap Stocks That Could Make You Filthy Rich

By Muslim Farooque, InvestorPlace Contributor
Cheap stocks offer a silver lining as the Fed takes a cautious stance, presenting opportunities for savvy investors.

Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for April 2024 

By Ian Cooper, InvestorPlace Contributor
Cannabis stocks could see higher highs. All thanks to legalization in Germany, and growing approval ratings in polls ahead of elections.

CGC Stock: What to Know Ahead of Canopy Growth’s Share Conversion Vote This Week

By Eddie Pan, InvestorPlace Financial News Writer
CGC stockholders will vote to create a new class of exchangeable shares on April 12. These shares will represent Canopy USA.

Why Is Ocugen (OCGN) Stock Up 7% Today?

By Dana Blankenhorn, InvestorPlace Contributor
Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results.

Sanofi Layoffs 2024: What to Know About the Latest SNY Job Cuts

By William White, InvestorPlace Writer
Sanofi layoffs are coming for the company's R&D employees and it makes major changes to how it handles development going forward.

Why Is Longeveron (LGVN) Stock Up 82% Today?

By William White, InvestorPlace Writer
Longeveron stock is up on Monday after the company announced plans for a proposed public offering of LGVN shares and warrants.

The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024

By Michael Que, InvestorPlace Contributor
Our economy is on the up and up, and investing is a must,. Let's review the most undervalued S&P 500 stocks to buy in April.

3 Stocks That Are Actually Worth Shorting for Endless Gains

By Omor Ibne Ehsan
These zombie stocks are on their last legs and diluting shareholders into oblivion, just to stay afloat a little longer.

OCGN Stock Alert: Why Is Ocugen Up 20% Today?

By Josh Enomoto, InvestorPlace Contributor
With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications.

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

By Andy Kim, InvestorPlace Contributor
The healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.

Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late

By Rick Orford, InvestorPlace Contributor
Investors might want to be wary and dump these expensive Nasdaq stocks to sell before their impending and potentially violent corrections.

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

By Joey Frenette, InvestorPlace Contributor
The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

TDOC Stock Is Down 95% Since 2021. Now the Teladoc CEO Is Leaving.

By William White, InvestorPlace Writer
Teladoc stock is a hot topic on Friday as investors in TDOC shares learn of the company's CEO departing and a search for a replacement.

SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson

By Dana Blankenhorn, InvestorPlace Contributor
JNJ is building a suite of heart disease treatment devices and hopes integration can help it avoid a patent cliff.
Load More Articles